$1.16
-0.09-7.2%
Last update: Nov 5, 6:33 PM
Palisade Bio Inc
PALINASDAQ
The average analyst price target for Palisade Bio is $10.10, 783.6% above the current price. Of 10 analysts, 10 rate it Buy. Targets range from $5 to $25. The latest change came on Oct 9, 2026, when Raymond James initiated coverage of Palisade Bio with an Outperform rating and a $6 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
